The chairman of the National Committee for Vaccination Activities Coordination ((CNCAV)), military physician Valeriu Gheorghita, on Tuesday said that people’s interest in scheduling for vaccination is high and announced the decision to notify only once a person on the waiting list, who will have 24 hours available to confirm that appointment.
“People’s interest in scheduling for vaccination is high, namely at the moment in the centres, for example, where the inoculation is made with the Pfizer vaccine, the rate of confirmation of appointments after notification is between 85-90% of the people on the waiting lists, even from the first notification. As we know so far, the rule was that a person is notified up to three times, after which, if he/she does not respond to that confirmation, other persons were notified instead. Since there are many people on the waiting list who are waiting to receive notifications, we have decided to notify a person on the waiting list only once, to have 24 hours to confirm. If the notified person does not confirm the appointment at the vaccination center within 24 hours, other persons on the waiting list will be notified,” the military doctor explained at a press conference.
He said that people who do not confirm their appointment after the first notification will be able to register on the waiting list of another center, or to be scheduled on the places that will be available in the vaccination centers and that will not have a waiting list.
Gheorghita said that this requirement will be operationalized starting Wednesday.
According to him, from April 10, it will be displayed on the programming platform, for each person who is on the waiting list, how many people are registered before him/her and what is the daily vaccination capacity in the vaccination center for which the respective person has opted.
11,252 adverse reactions cases reported since vaccination campaign onset
Military physician Valeriu Gheorghita said that since the beginning of the COVID-19 vaccination campaign, 11,252 cases of adverse reactions have been reported, which means a reporting rate of 3.4 cases per 1,000 doses administered.
“In terms of the situation of adverse reactions reported since the onset of the vaccination campaign and up to this point, there have been 11,252 cases of adverse reactions reported, which means a reporting rate of 3.4 cases per 1,000 doses administered. Regarding the reporting rate by type of vaccine, for Pfizer-BioNTech we have a reporting rate of about 1.9 adverse reactions per 1,000 doses administered, for Moderna 3.6 adverse reactions per about 1,000 doses administered, and 13.1 for AstraZeneca per 1,000 doses administered,” Valeriu Gheorghita said on Tuesday at a press conference at the Victoria Palace of Government.
He also specified that 1,110 adverse reactions were reported between March 29 and April 4, most of them, more than 93 pct, being centralized at the National Agency for Medicines and Medical Devices.
“The average age of people who reported these adverse reactions is 37 years, so we see a higher prevalence in the younger age group and over 63 pct of people who have reported these adverse reactions are female. Depending on the severity of the events, no severe adverse reactions were reported in the previous week, the 1,109 reactions are classified as non-severe. Depending on the type of adverse reactions, 73 pct of them are local reactions, with pain, swelling, rash at the site of administration and systemic phenomena with fatigue, fever and chills, 39 pct muscle or joint pain, 42 pct headache, 17 pct digestive reactions,” Gheorghita explained.
“The CNCAV head has also presented a stocktaking report of the vaccinated persons since the beginning of the campaign, stating that by April 5 2,132,024 people were vaccinated, of whom “over 1,220,000 are people vaccinated with two doses.”